If you find this podcast useful please give it a rating and review on iTunes by clicking here
Do you want to get instant company alerts to the front screen of your smartphone? Download the Vox Markets app here: www.VoxMarkets.co.uk/app
On today's Vox Markets Podcast: Integumen and Russ Mould on the Global Economy, Two Growth Stocks and One Income Stock
Gerry Brandon, Chief Executive Officer of Integumen (SKIN) explains the business model, the progress he's achieved since taking control and the potential going forward.
Integumen is a vertically integrated business, collaborating their Labskin technology platform with partners in artificial intelligence, clinical research, medical device and life science. These collaborators are building their own technology on top of the Labskin AI backbone. Labskin allows skin-care, health-care, pharmaceutical manufacturers and cosmetic companies to test their products on human-like skin in a real-world environment with full access to multiple state-of-the-art partner technologies. The Company combines data analytics with access to therapeutic operational expertise and offers solutions to our clients, from regulatory approvals, right through to marketing fully tested ingredients that have been certified on our Laboratory grown living human tissue.
Russ Mould, Investment Director at stockbroker AJ Bell talks about the global economy and the following stocks:
Franchise Brands (FRAN)
Zytronic (ZYT)
Persimmon (PSN)
(Interview starts at 25 minutes 35 seconds)